NURCHI, VALERIA MARINA
 Distribuzione geografica
Continente #
EU - Europa 246.978
NA - Nord America 16.662
AS - Asia 6.592
SA - Sud America 1.037
Continente sconosciuto - Info sul continente non disponibili 578
AF - Africa 178
OC - Oceania 29
Totale 272.054
Nazione #
IT - Italia 240.027
US - Stati Uniti d'America 16.374
NL - Olanda 2.973
SG - Singapore 2.484
CN - Cina 2.301
UA - Ucraina 1.148
BR - Brasile 813
SE - Svezia 802
VN - Vietnam 528
DE - Germania 517
FI - Finlandia 444
GB - Regno Unito 367
FR - Francia 324
HK - Hong Kong 202
IN - India 193
KR - Corea 170
CA - Canada 169
BD - Bangladesh 151
TR - Turchia 74
IQ - Iraq 73
RU - Federazione Russa 71
AR - Argentina 65
MX - Messico 64
IR - Iran 54
ES - Italia 53
JP - Giappone 53
ZA - Sudafrica 52
PL - Polonia 51
EC - Ecuador 40
PK - Pakistan 39
ID - Indonesia 36
UZ - Uzbekistan 35
AT - Austria 30
CO - Colombia 29
MY - Malesia 29
BE - Belgio 28
AU - Australia 27
EG - Egitto 23
PH - Filippine 23
VE - Venezuela 23
IE - Irlanda 22
MA - Marocco 22
JM - Giamaica 21
CL - Cile 20
TN - Tunisia 20
CH - Svizzera 19
TH - Thailandia 18
UY - Uruguay 18
SA - Arabia Saudita 17
IL - Israele 14
KE - Kenya 14
PE - Perù 13
CR - Costa Rica 11
DZ - Algeria 11
LY - Libia 11
SY - Repubblica araba siriana 11
CZ - Repubblica Ceca 10
JO - Giordania 10
GR - Grecia 9
RO - Romania 9
AL - Albania 8
AZ - Azerbaigian 8
BG - Bulgaria 8
PY - Paraguay 8
RS - Serbia 8
TW - Taiwan 8
AE - Emirati Arabi Uniti 7
BO - Bolivia 7
DK - Danimarca 7
LB - Libano 7
KZ - Kazakistan 6
LT - Lituania 6
NP - Nepal 6
PT - Portogallo 6
SK - Slovacchia (Repubblica Slovacca) 6
AM - Armenia 5
BY - Bielorussia 5
ET - Etiopia 5
HU - Ungheria 5
MD - Moldavia 5
NG - Nigeria 5
PS - Palestinian Territory 5
CI - Costa d'Avorio 4
EU - Europa 4
GT - Guatemala 4
LK - Sri Lanka 4
SN - Senegal 4
TT - Trinidad e Tobago 4
BB - Barbados 3
BH - Bahrain 3
KG - Kirghizistan 3
MN - Mongolia 3
PA - Panama 3
BS - Bahamas 2
BW - Botswana 2
EE - Estonia 2
GD - Grenada 2
GE - Georgia 2
HN - Honduras 2
IS - Islanda 2
Totale 271.453
Città #
Cagliari 235.232
Uta 3.910
Amsterdam 2.942
Fairfield 1.696
Ashburn 1.339
Woodbridge 1.283
Singapore 1.124
San Jose 934
Houston 886
Chandler 832
Dallas 735
Wilmington 696
Ann Arbor 688
Boardman 684
Seattle 638
Jacksonville 621
Cambridge 588
Nyköping 573
Beijing 419
Dearborn 338
Council Bluffs 287
Los Angeles 275
Helsinki 260
Santa Clara 199
Nanjing 195
Boston 191
Lauterbourg 190
The Dalles 190
Hong Kong 173
Ho Chi Minh City 163
Hefei 161
Seoul 153
New York 150
Hanoi 127
Shanghai 123
Buffalo 121
San Diego 96
Escalaplano 79
Guangzhou 73
Nanchang 72
São Paulo 71
Redwood City 70
Milan 63
Shenyang 61
Dong Ket 60
Hebei 57
London 54
Orem 52
Toronto 52
Mountain View 51
Tianjin 51
Atlanta 50
Changsha 49
Redondo Beach 46
Chicago 44
Columbus 42
Chennai 41
Jiaxing 39
Verona 39
Baghdad 35
Frankfurt am Main 34
Norwalk 33
Ottawa 33
Tokyo 33
Rome 32
Sassari 32
Tashkent 32
Zhengzhou 32
Brooklyn 31
Rio de Janeiro 30
Da Nang 27
Jinan 26
Orange 26
Brussels 25
Phoenix 25
Warsaw 25
Nuremberg 24
Washington 24
Dhaka 23
Hangzhou 23
Pune 21
Las Vegas 20
Auburn Hills 18
Haiphong 18
Montreal 18
Ningbo 18
Dublin 17
Istanbul 17
Johannesburg 17
Paris 17
Wuhan 17
Brasília 16
Manchester 16
Pars 16
San Francisco 16
Charlotte 15
Denver 15
Falls Church 15
Belo Horizonte 14
Curitiba 13
Totale 261.367
Nome #
Iron Chelation for Iron Overload in Thalassemia 5.751
A new bis-3-hydroxy-4-pyrone as a potential therapeutic iron chelating agent. Effect of connecting and side chains on the complex structures and metal ion selectivity 3.859
Hydroxypyridinones with enhanced iron chelating properties. Synthesis, characterization and in vivo tests of 5-hydroxy-2-(hydroxymethyl)pyridine-4(1H)-one 3.639
Complex formation equilibria of Cu2 + and Zn2 + with Irbesartan and Losartan 3.553
para-Aminosalicylic acid in the treatment of manganese toxicity. Complexation of Mn2+ with 4-amino-2-hydroxybenzoic acid and its N-acetylated metabolite 3.543
Multiple Sclerosis and environmental factors. 3.300
Gold - Old drug with new potentials 3.229
Simple solid-phase spectrophotometric method for free iron(III) determination 3.083
Metal coordination and tyrosinase inhibition studies with Kojic-βAla-Kojic 2.962
Sampling variability in hepatic iron concentration in beta-thalassemia 2.873
Searching for new aluminium chelating agents: a family of hydroxypyrone ligands 2.802
Salicylamide derivatives for iron and aluminium sequestration. From synthesis to complexation studies 2.753
The essential metals for humans: a brief overview 2.709
Assessment, validation and application to real samples of an RP-HPLC method for the determination of Guayulins A, B, C and D in Guayule Shrub 2.660
Looking at new ligands for chelation therapy 2.567
Sorption of ofloxacin and chrysodine by grape stalk. A representative case of biomass removal of emerging pollutants from wastewater 2.545
Depleted uranium and human health 2.472
A new tripodal-3-hydroxy-4-pyridinone for iron and aluminium sequestration: synthesis, complexation and in vivo studies 2.445
Copper-Induced Epigenetic Changes Shape the Clinical Phenotype in Wilson's Disease 2.441
A new tripodal kojic acid derivative for iron sequestration: Synthesis, protonation, complex formation studies with Fe3+, Al3+, Cu2+ and Zn2+, and in vivo bioassays 2.416
Kojic acid derivatives as powerful chelators for iron(III) and aluminium(III) 2.306
Gold nanoparticles: A new golden Era in oncology? 2.279
Metal self-assembly mimosine peptides with enhanced antimicrobial activity: towards a new generation of multitasking chelating agentsts 2.261
Chelating principles in Menkes and Wilson diseases: Choosing the right compounds in the right combinations at the right time 2.238
Iron(III) and aluminum(III) complexes with hydroxypyrone ligands aimed to design kojic acid derivatives with new perspectives 2.235
A review on coordination properties of thiol-containing chelating agents towards mercury, cadmium, and lead 2.231
New insights into the protogenic and spectroscopic properties of commercial tannic acid: the role of gallic acid impurities 2.217
Do anti-diabetic drugs act as copper ligands? 2.214
Free fluoride determination in honey by ion-specific electrode potentiometry: method assessment, validation and application to real unifloral samples 2.201
Toxicity of nanoparticles: etiology and mechanisms 2.158
New strong extrafunctionalizable tris(3,4-HP) and bis(3,4-HP) metal sequestering agents: synthesis, solution and in vivo metal chelation 2.119
Arsenic toxicity: Molecular targets and therapeutic agents 2.082
Equilibrium studies of new bis-hydroxypyrone derivatives with Fe3+, Al3+, Cu2+ and Zn2+ 2.077
Tungsten or wolfram: Friend or foe? 2.057
Zinc(II) and copper(II) complexes with hydroxypyrone iron chelators 2.044
Complex formation equilibria of polyamine ligands with copper(II) and zinc(II) 2.033
Chelation therapy for metal intoxication. Comments from a thermodynamic view point 1.979
Fluoroquinolones: A micro-species equilibrium in the protonation of amphoteric compounds 1.970
Editorial: Applications of Medicinal Bioinorganic Chemistry 1.960
The meaning of aluminium exposure on human health and aluminium-related diseases 1.936
Kill or cure: Misuse of chelation therapy for human diseases 1.929
A new hydroxypyrone powerful chelator. From synthesis to AlIII, FeIII, CuII and ZnII complex formation equilibria, and structural characterization 1.902
A portable, disposable, and low-cost optode for sulphide and thiol detection 1.900
Substituent effects on ionization constants as a predictive tool of coordinating ability 1.896
Silver coordination compounds: A new horizon in medicine 1.876
Alarming use of chelation therapy 1.853
Inexpensive Alizarin Red S-based optical device for the simultaneous detection of Fe(III) and Al(III) 1.852
Iron III and aluminium III complexes with substituted salicyl-aldehydes and salicylic acids 1.840
Oxovanadium(IV) coordination compounds with kojic acid derivatives in aqueous solution 1.832
Chemical features of in use and in progress chelators for iron overload 1.831
Interaction of a chelating agent, 5-hydroxy-2-(hydroxymethyl)pyridin-4(1H)-one, with Al(III), Cu(II) and Zn(II) ions 1.827
(5-Hydroxy-4-oxo-4H-pyran-2-yl)methyl3-({[(5-hydroxy-4-oxo-4H-pyran-2-yl)methoxy] carbonyl}amino) propanoate. Synthesis and its complex formation study 1.806
Comparison of selectivity of a family of chelating agents for trivalent (Al3+, Fe3+) and bivalent (Cu2+, Zn2+) metal ions 1.800
State of art in chelating agents for the clinical treatment of metal poisoning 1.797
Noble metals in medicine: Latest advances 1.792
An NMR study on the 6,6'-(2-(diethylamino)ethylazanediyl)bis(methylene)bis(5-hydroxy-2-hydroxymethyl-4H-pyran-4-one) interaction with Al(III) and Zn(II) ions 1.784
Biomonitoring of toxic element exposure by ICP-AES and ICP-MS analysis 1.779
Hydroxypyrones, an intriguing family of chelating agents for Fe(III) and Al(III) 1.769
5-hydroxy-2-(hydroxymethyl)pyridin-4(1H)-one molecule as an intriguing tool in coordination and enzymatic studies 1.766
A speciation study on the perturbing effects of iron chelators on the homeostasis of essential metal ions 1.743
Unusual PLS application for Pd(ii) sensing in extremely acidic solutions 1.735
Medical uses of silver: history, myths and scientific evidence 1.735
A family of hydroxypyrone ligands designed and synthesized for iron chelators 1.715
Chelating agents as therapeutic compounds - Basic principles 1.713
null 1.693
Sorption of chrysoidine by row cork and cork entrapped in calcium alginate beads 1.691
The Role of Magnesium in Pregnancy and in Fetal Programming of Adult Diseases 1.686
Uneven hepatic iron and phosphorus distribution in b-thalassemia 1.662
Losartan: a low water soluble oral drug with Cu(II) and Zn(II) coordination properties 1.628
Uneven hepatic copper distribution in Wilson's disease 1.625
Competition between Cd(II) and other divalent transition metal ions during complex formation with amino acids, peptides, and chelating agents 1.616
Trace elements and the carotid plaque: the GOOD (Mg, Zn, Se), the UGLY (Fe, Cu), and the BAD (P, Ca)? 1.616
Synthesis and Mass Spectrometry Analysis of Mimosine-Containing Peptides 1.591
Chelating agents for human diseases related to aluminium overload 1.563
Iron and other metals in the pathogenesis of Parkinson's disease: Toxic effects and possible detoxification 1.525
Uneven cardiac iron distribution in beta-thalassemia 1.515
Biomass against emerging pollution in wastewatee 1.492
Medicinal bio-inorganic chemistry: papers from the Third International Summer School of Bioinorganic Medicinal Chemistry, Cagliari, Italy 1.434
Optimization of a newly established gas-chromatographic method for determining lactose and galactose traces: Application to Pecorino Romano cheese 1.399
Toxicity of nanoparticles 1.388
Development of a sensor for trivalent iron: AHP fixed on mesoporous silica 1.323
Copper(II) and Nickel(II) uptake from aqueous solutions by cork wastes: a NMR and potentiometric study 1.313
Biomass against emerging pollution in wastewater: Ability of cork for the removal of ofloxacin from aqueous solutions at different pH 1.311
Chelating agents for metal intoxication 1.310
The Potential Clinical Properties of Magnesium 1.308
Deferoxamine-paper for iron(III) and vanadium(V) sensing 1.254
Metal ion toxicity 1.243
Iron chelating agents for iron overload diseases 1.241
Analytical determination of total acidity in some Sardinian wines: evaluation of the contribute of different acids 1.240
Molecular recognition between adenine or 2,6-diaminopurine and copper(II) chelates with N,O2,S-tripodal tetradentate chelators having thioether or disulfide donor groups. 1.238
Warns against unapproved ‘chelation therapy’ 1.207
null 1.188
Medical therapy of patients contaminated with radioactive cesium or iodine 1.172
Substituent effects on ionisation and 13C NMR properties of some monosubstituted phenols. A potentiometric, spectrophotometric and 13C NMR study 1.171
Thermodynamic Study of Oxidovanadium(IV) with Kojic Acid Derivatives: A Multi-Technique Approach 1.166
Metal ions in the pathogenesis of Alzheimer’s disease: an open field 1.164
The aging kidney—as influenced by heavy metal exposure and selenium supplementation 1.120
Complex formation equilibria of Cu(II) and Zn(II) with triethylenetetramine and its mono- and di-acetyl metabolites 1.116
null 1.075
Substituent effect on the stability of iron(III)-salicylate complexes. Structure of trans-[Fe(H5Nsal) 2(H2O)2]Cl·2H2O 1.072
Totale 197.027
Categoria #
all - tutte 365.643
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 365.643


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202211.062 0 1.310 696 960 1.077 949 652 479 891 1.213 1.478 1.357
2022/202317.894 1.410 1.911 2.066 1.412 1.487 2.109 997 2.372 1.204 920 1.158 848
2023/202419.038 1.041 839 846 1.302 2.034 3.370 2.863 1.276 726 1.437 1.687 1.617
2024/202541.563 10.259 11.022 4.737 3.838 2.235 2.611 3.586 261 510 1.530 404 570
2025/202614.105 754 497 1.452 896 657 949 2.547 1.029 3.135 1.158 703 328
2026/2027722 179 543 0 0 0 0 0 0 0 0 0 0
Totale 272.054